Clinical trial data consistently shows that tirzepatide before and after results tend to be more dramatic than those seen with semaglutide alone
Normal injection site reactions typically include: Mild swelling or firmness that usually subsides within a few days, gradually diminishing without treatment Slight redness (erythema) around the injection point, typically limited in size Minimal tenderness that does not interfere with daily activities Small bruises that change colour from red-purple to yellow-green as they resolve Lipohypertrophy lumps that are painless, non-inflamed, and develop slowly over time These reactions are documented in Saxenda's Summary of Product Characteristics, with injection site reactions categorised as 'common' (affecting up to 1 in 10 people)
Veuillez toujours lire l'tiquette, les avertissements et les instructions fournis sur le produit avant de l'utiliser ou de le consommer
PLoS One 8 , e61965 (2013)
Based on progress and any side effects, the provider may adjust the dosage
STELARA is the only FDA-approved medication that targets these two proteins